Skip to main content
NCBI home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1999 May;170(5):274–277.

Recurrent cystitis in nonpregnant women.

L D Chew 1, S D Fihn 1
PMCID: PMC1305583  PMID: 10379218

Abstract

Consistent evidence from RCTs shows that antibiotic prophylaxis (either continuous or postcoital), using trimethoprim TMP-SMZ, nitrofurantoin, or a quinolone, reduces infection rates in women with high rates of recurrent cystitis (at least two per year). Limited evidence suggests that intermittent patient-administered treatment (taken at the onset of symptoms) is an effective alternative management strategy to continuous antibiotic prophylaxis in women with high rates of infection (at least two per year). Limited evidence suggests that long-term prophylaxis is likely to benefit women with a baseline rate of more than two infections per year over many years. However, long-term treatment has not yet been evaluated in RCTs. In women who experience recurrent, uncomplicated cystitis, there is no evidence to support routine investigation of the urinary tract with excretory urography, ultrasonography, cystoscopy, or voiding cystourethrography. No specific subgroups of women who would clearly benefit from investigation have yet been adequately defined.

Full text

PDF
274

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brumfitt W., Hamilton-Miller J. M. A comparative trial of low dose cefaclor and macrocrystalline nitrofurantoin in the prevention of recurrent urinary tract infection. Infection. 1995 Mar-Apr;23(2):98–102. doi: 10.1007/BF01833874. [DOI] [PubMed] [Google Scholar]
  2. Brumfitt W., Hamilton-Miller J. M., Smith G. W., al-Wali W. Comparative trial of norfloxacin and macrocrystalline nitrofurantoin (Macrodantin) in the prophylaxis of recurrent urinary tract infection in women. Q J Med. 1991 Oct;81(294):811–820. [PubMed] [Google Scholar]
  3. Brumfitt W., Smith G. W., Hamilton-Miller J. M., Gargan R. A. A clinical comparison between Macrodantin and trimethoprim for prophylaxis in women with recurrent urinary infections. J Antimicrob Chemother. 1985 Jul;16(1):111–120. doi: 10.1093/jac/16.1.111. [DOI] [PubMed] [Google Scholar]
  4. Engel G., Schaeffer A. J., Grayhack J. T., Wendel E. F. The role of excretory urography and cystoscopy in the evaluation and management of women with recurrent urinary tract infection. J Urol. 1980 Feb;123(2):190–191. doi: 10.1016/s0022-5347(17)55849-8. [DOI] [PubMed] [Google Scholar]
  5. Fair W. R., McClennan B. L., Jost R. G. Are excretory urograms necessary in evaluating women with urinary tract infection? J Urol. 1979 Mar;121(3):313–315. doi: 10.1016/s0022-5347(17)56766-x. [DOI] [PubMed] [Google Scholar]
  6. Fihn S. D., Latham R. H., Roberts P., Running K., Stamm W. E. Association between diaphragm use and urinary tract infection. JAMA. 1985 Jul 12;254(2):240–245. [PubMed] [Google Scholar]
  7. Fowler J. E., Jr, Pulaski E. T. Excretory urography, cystography, and cystoscopy in the evaluation of women with urinary-tract infection: a prospective study. N Engl J Med. 1981 Feb 19;304(8):462–465. doi: 10.1056/NEJM198102193040805. [DOI] [PubMed] [Google Scholar]
  8. Hooton T. M., Scholes D., Hughes J. P., Winter C., Roberts P. L., Stapleton A. E., Stergachis A., Stamm W. E. A prospective study of risk factors for symptomatic urinary tract infection in young women. N Engl J Med. 1996 Aug 15;335(7):468–474. doi: 10.1056/NEJM199608153350703. [DOI] [PubMed] [Google Scholar]
  9. Melekos M. D., Asbach H. W., Gerharz E., Zarakovitis I. E., Weingaertner K., Naber K. G. Post-intercourse versus daily ciprofloxacin prophylaxis for recurrent urinary tract infections in premenopausal women. J Urol. 1997 Mar;157(3):935–939. [PubMed] [Google Scholar]
  10. Nickel J. C., Wilson J., Morales A., Heaton J. Value of urologic investigation in a targeted group of women with recurrent urinary tract infections. Can J Surg. 1991 Dec;34(6):591–594. [PubMed] [Google Scholar]
  11. Nicolle L. E., Harding G. K., Thompson M., Kennedy J., Urias B., Ronald A. R. Prospective, randomized, placebo-controlled trial of norfloxacin for the prophylaxis of recurrent urinary tract infection in women. Antimicrob Agents Chemother. 1989 Jul;33(7):1032–1035. doi: 10.1128/aac.33.7.1032. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Pfau A., Sacks T. G. Effective postcoital quinolone prophylaxis of recurrent urinary tract infections in women. J Urol. 1994 Jul;152(1):136–138. doi: 10.1016/s0022-5347(17)32837-9. [DOI] [PubMed] [Google Scholar]
  13. Pfau A., Sacks T., Engelstein D. Recurrent urinary tract infections in premenopausal women: prophylaxis based on an understanding of the pathogenesis. J Urol. 1983 Jun;129(6):1153–1157. doi: 10.1016/s0022-5347(17)52617-8. [DOI] [PubMed] [Google Scholar]
  14. Raz R., Boger S. Long-term prophylaxis with norfloxacin versus nitrofurantoin in women with recurrent urinary tract infection. Antimicrob Agents Chemother. 1991 Jun;35(6):1241–1242. doi: 10.1128/aac.35.6.1241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Stamm W. E., Counts G. W., McKevitt M., Turck M., Holmes K. K. Urinary prophylaxis with trimethoprim and trimethoprim-sulfamethoxazole: efficacy, influence on the natural history of recurrent bacteriuria, and cost control. Rev Infect Dis. 1982 Mar-Apr;4(2):450–455. doi: 10.1093/clinids/4.2.450. [DOI] [PubMed] [Google Scholar]
  16. Stamm W. E., Counts G. W., Wagner K. F., Martin D., Gregory D., McKevitt M., Turck M., Holmes K. K. Antimicrobial prophylaxis of recurrent urinary tract infections: a double-blind, placebo-controlled trial. Ann Intern Med. 1980 Jun;92(6):770–775. doi: 10.7326/0003-4819-92-6-770. [DOI] [PubMed] [Google Scholar]
  17. Stamm W. E., McKevitt M., Roberts P. L., White N. J. Natural history of recurrent urinary tract infections in women. Rev Infect Dis. 1991 Jan-Feb;13(1):77–84. doi: 10.1093/clinids/13.1.77. [DOI] [PubMed] [Google Scholar]
  18. Stapleton A., Latham R. H., Johnson C., Stamm W. E. Postcoital antimicrobial prophylaxis for recurrent urinary tract infection. A randomized, double-blind, placebo-controlled trial. JAMA. 1990 Aug 8;264(6):703–706. [PubMed] [Google Scholar]
  19. Wong E. S., McKevitt M., Running K., Counts G. W., Turck M., Stamm W. E. Management of recurrent urinary tract infections with patient-administered single-dose therapy. Ann Intern Med. 1985 Mar;102(3):302–307. doi: 10.7326/0003-4819-102-3-302. [DOI] [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES